Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.40 +0.21 (+0.60%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 22, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,987,173
Open	35.00
Bid (Size)	35.42 (100)
Ask (Size)	35.60 (100)
Prev. Close	35.19
Today's Range	34.84 - 35.80
52wk Range	18.92 - 43.55
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech

December 19, 2025

NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On...

Via MarketMinute

The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025

December 18, 2025

As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,...

Via MarketMinute

Performance

YTD	-13.9%	-13.9%
1 Month	+2.2%	+2.2%
3 Month	+34.9%	+34.9%
6 Month	+42.4%	+42.4%
1 Year	-16.4%	-16.4%

More News

Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years? ↗

November 06, 2025

Via Stocktwits

Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics ↗

December 18, 2025

Via Stocktwits

2 Growth Stocks to Invest $1,000 in Right Now ↗

December 18, 2025

Via The Motley Fool

1 Bold Prediction for Viking Therapeutics in 2026 ↗

December 16, 2025

Via The Motley Fool

2 Monster Stocks in the Making to Buy and Hold ↗

December 16, 2025

Via The Motley Fool

My Top 10 Stocks to Buy for 2026 ↗

December 13, 2025

Via The Motley Fool

3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 ↗

December 11, 2025

Via The Motley Fool

What's Up With The Jump In Viking Therapeutics Stock? ↗

December 04, 2025

Via Benzinga

Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗

November 27, 2025

Via The Motley Fool

Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗

November 25, 2025

Via Stocktwits

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗

November 22, 2025

Via The Motley Fool

3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗

November 21, 2025

Via The Motley Fool

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

November 19, 2025

Via The Motley Fool

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

Via The Motley Fool

2 No-Brainer Healthcare Stocks to Buy Now ↗

November 18, 2025

Via The Motley Fool

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Via Benzinga

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

November 13, 2025

Via Stocktwits

‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗

November 11, 2025

Via Stocktwits

AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today ↗

November 11, 2025

Via Benzinga

2 Monster Stocks in the Making ↗

November 10, 2025

Via The Motley Fool

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗

November 09, 2025

Via Stocktwits

Is There a Future for Viking Therapeutics? ↗

November 09, 2025

Via The Motley Fool

The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗

November 07, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 35.40

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 12/22/25 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.53B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.